Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.50 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.37 |
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.36 |
| ▸ | DPP4 | P27487 | 2/20 | 0.36 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | FAP | Q12884 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1173223 | 1.00 | GSR (0.50) | GSRGNAI3GNAO1GNAI1DPP7 | |
| Hydrochloric Acid SCHEMBL11573551 | 0.98 | GSR (0.48) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL28831690 | 0.98 | GSR (0.48) | GSRGNAI3GNAO1GNAI1DPP7 | |
| Water SCHEMBL6560978 | 0.98 | GSR (0.48) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL28831704 | 0.98 | GSR (0.48) | GSRGNAI3GNAO1GNAI1DPP7 | |
| Water SCHEMBL6034325 | 0.98 | GSR (0.48) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL5532328 | 0.95 | GSR (0.42) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL6850412 | 0.95 | GSR (0.42) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL8508994 | 0.93 | GSR (0.47) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL1191631 | 0.93 | GSR (0.53) | GSRGNAI3GNAO1GNAI1DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12178874-B2 | Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof | JUST-EVOTEC BIOLOGICS, INC. (US) | 2024-12-31 | — | — | US | claimed |
| US-9555063-B2 | Pluripotent therapeutic compositions and uses thereof | IMMUNOPATH PROFILE, INC. (US) | 2017-01-31 | — | — | US | claimed |
| US-20140193368-A1 | PLURIPOTENT THERAPEUTIC COMPOSITIONS AND USES THEREOF | IMMUNOPATH PROFILE, INC. (US) | 2014-07-10 | — | — | US | claimed |
| US-20090274660-A1 | Synthetic Stem Cell-like Tissue Healing and Regeneration Medication; nutraceuticals; glycosaminoglycan, polar surface active lipid such as lecithin, enantiomerically pure L-amino acids and glycine, vitamins, sorbitan fatty esters or grapeseed extract | IMMUNOPATH PROFILE, INC. (US) | 2009-11-05 | — | — | US | claimed |
| EP-0554435-B1 | PROCESS FOR OBTAINING A PHENYLALANINE-FREE DIETARY PRODUCT IN PILL OR TABLET FORM | MILUPA AG (DE) | 1995-12-20 | — | — | EP | claimed |
| US-4415590-A | Herpes treatment | BETAMED PHARMACEUTICALS, INC. (US) | 1983-11-15 | — | — | US | claimed |
| US-4052372-A | FROM LYSINE GLUTAMATE | SOCIETE D'ASSISTANCE TECHNIQUE POUR PRODUITS NESTLE S.A. (CH) | 1977-10-04 | — | — | US | claimed |
| CN-122055143-A | Solid compositions containing bromhexine | 第一三共健康事业株式会社 | 2026-05-15 | — | — | CN | disclosed |
| WO-2025105451-A1 | SOLID PREPARATION | 第一三共ヘルスケア株式会社 | 2025-05-22 | — | — | WO | disclosed |
| CN-119278035-A | Solid preparation and method for producing the same | 第一三共健康事业株式会社 | 2025-01-07 | — | — | CN | disclosed |
| US-12178874-B2 | Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof | JUST-EVOTEC BIOLOGICS, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| EP-4442126-A2 | ORAL COMPOSITION WITH INCREASED SWEETNESS | Suntory Holdings Limited (JP) | 2024-10-09 | — | — | EP | disclosed |
| CN-118667894-A | Process for preparing 5-aminopentanamide and 5-aminopentanoic acid | 广安摩珈生物科技有限公司 | 2024-09-20 | — | — | CN | disclosed |
| EP-0655971-A1 | PARTICLE BINDERS | WEYERHAEUSER COMPANY (US) | 1995-06-07 | — | — | EP | disclosed |
| WO-1994004351-A1 | PARTICLE BINDING TO FIBERS | WEYERHAEUSER COMPANY (US) | 1994-03-03 | — | — | WO | disclosed |
| WO-1994004352-A1 | PARTICLE BINDERS | WEYERHAEUSER COMPANY (US) | 1994-03-03 | — | — | WO | disclosed |
| EP-0142059-A2 | Method of heat-treating plasma proteins | GREEN CROSS CORPORATION (JP) | 1985-05-22 | — | — | EP | disclosed |
| US-4415590-A | Herpes treatment | BETAMED PHARMACEUTICALS, INC. (US) | 1983-11-15 | — | — | US | disclosed |
| US-4415590-A | Herpes treatment | BETAMED PHARMACEUTICALS, INC. (US) | 1983-11-15 | — | — | US | disclosed |
| US-4052372-A | FROM LYSINE GLUTAMATE | SOCIETE D'ASSISTANCE TECHNIQUE POUR PRODUITS NESTLE S.A. (CH) | 1977-10-04 | — | — | US | disclosed |